Report
Fatma Agnès Hamdani

Glanbia : FY results broadly in line with slightly better organic growth than consensus. A new SBB of € 100m is announced

>Organic sales growth of -8.2% (vs css -8.8%) hit by pricing, while EBITA margin is in line at 7.8% - Glanbia reported sales of $ 5.4bn in 2023, which is next to estimates. Organic sales came in at -8.2%, better than the consensus forecast and below ours on lower pricing for Glanbia Nutrition. GPN delivered +4.8% in line with expectations, driving by pricing. The decline in volumes is mainly driven by the SlimFast brand in the US. ON brand is growing by 17% both in v...
Underlying
Glanbia Plc

Glanbia is a performance nutrition and ingredients group, engaged in providing performance nutrition, cheese, dairy ingredients, specialty non-dairy ingredients and vitamin and mineral premixes. Co. segments include: Global Performance Nutrition, which is involved in the branded performance nutrition business; Global Ingredients, which manufactures cheddar cheese, provides dairy and non-dairy nutritional ingredients and micro-nutrient premixes; Dairy Ireland, which is engaged in the manufacture and sale of a range of consumer products and farm inputs; and Joint Ventures & Associates, which is engaged in the manufacture and sale of cheese, dairy ingredients and dairy consumer products.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Fatma Agnès Hamdani

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch